7150 analyzer

Manufactured by Hitachi

Sourced in Japan

The Hitachi 7150 analyzer is a compact and versatile laboratory instrument designed for performing a wide range of analytical tests. It is capable of quickly and accurately analyzing various samples, including liquids, solids, and gases. The 7150 analyzer utilizes advanced technology to provide reliable and reproducible results, making it a valuable tool for various industries and research applications.

Automatically generated - may contain errors

Lab products found in correlation

Hematology analyzer, by Beckman Coulter (1 mentions)

Close spelling variants of this product

7150 automated analyzer 7150 automatic biochemical analyzer

4 protocols using 7150 analyzer

Measuring HbA1c and Lipid Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols

To measure HbA_1c, blood was collected in tubes containing ethylenediaminetetraacetic acid. The stable and unstable fractions of HbA_1c were measured by a high-pressure liquid chromatography method (Hi-Auto A1c analyzer system; Kyoto Daiichi Kagaku, Kyoto, Japan). Stable form data were used in the present analysis. HbA_1c was expressed as the value of the national glycohemoglobin standardization program (NGSP).
Plasma total cholesterol and triglyceride levels were measured enzymatically using kits from Nippon Shoji Co, Ltd (Osaka, Japan) and a 7150 analyzer (Hitachi, Ltd, Tokyo, Japan). Serum high-density lipoprotein cholesterol was measured using a selective inhibition assay (Daiichi Pure Chemicals Co, Ltd, Tokyo, Japan).20 (link) Serum LDL cholesterol levels were calculated using the Friedewald formula.

Ohira M., Yamaguchi T., Saiki A., Ban N., Kawana H., Nagumo A., Murano T., Shirai K, & Tatsuno I. (2014). Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 313-319.

+ Open protocol

+ Expand

Evaluation of Liver Disease Indicators

Check if the same lab product or an alternative is used in the 5 most similar protocols

All patients were evaluated on standard laboratory parameters. The complete blood count was measured on Hematology Analyzer (Beckman Coulter 5 diff, Miami FL) and clinical chemistry tests were performed using 7150 Analyzer (Hitachi, Japan). All recorded indicators were from blood routine examination, coagulation function, liver and kidney function, serum lipid, myocardial enzyme and demographic characteristics. Thirty-nine variables were excluded in this study, because of literature and medical background (28 predictors such as Chlorine, Urea, Uric acid), as well as over-missing values (11 predictors such as C-reactive protein, Hepatitis b E antigen, HBeAb, HBV-DNA).
The variable “sign” is primarily considered as an indicator of clinical feature, which represents the status and symptoms of patients. If a patient had both liver palms and spider nevus, the “sign” was assigned to 2. If a patient had either liver palms or spider nevus, the “sign” was assigned to 1. If a patient has neither liver palms nor spider nevus, the “sign” was assigned to 0.

Xu X., Wang W., Zhang Q., Cai W., Wu M., Qin T, & Liu H. (2021). A Generic Nomogram Predicting the Stage of Liver Fibrosis Based on Serum Biochemical Indicators Among Chronic Hepatitis B Patients. Frontiers in Medicine, 8, 669800.

+ Open protocol

+ Expand

Measurement of HbA1c and Lipid Profiles

Check if the same lab product or an alternative is used in the 5 most similar protocols

To measure HbA1c, blood was collected in tubes containing ethylenediaminetetraacetic acid. The stable and unstable fractions of HbA1c were measured by a high-pressure liquid chromatography method (Hi-Auto A1C analyzer system; Kyoto Daiichi Kagaku, Kyoto, Japan). Data of stable form were used in the present analysis. HbA1c was expressed as the value of the National Glycohemoglobin Standardization Program.
Plasma total cholesterol and triglyceride levels were measured enzymatically using kits from Nippon Shoji Co, Ltd (Osaka, Japan) and a 7150 Analyzer (Hitachi, Ltd, Tokyo, Japan). Serum high-density lipoprotein cholesterol was measured using a selective inhibition assay (Daiichi Pure Chemicals Co, Ltd, Tokyo, Japan). Serum LDL-cholesterol level was calculated using the Friedwald formula.

Yamaguchi T., Shirai K., Nagayama D., Nakamura S., Oka R., Tanaka S., Watanabe Y., Imamura H., Sato Y., Kawana H., Ohira M., Saiki A., Shimizu N, & Tatsuno I. (2019). Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus. Journal of Atherosclerosis and Thrombosis, 26(7), 659-669.

+ Open protocol

+ Expand

Comprehensive Hematological and Biochemical Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols

Venous blood samples from fossa orbitalis were drawn and collected in 1.5-mL Eppendorf tubes coated with Na2-EDTA for the measurement of the hematological parameters, using a Sysmex XT-1800i hematology analyzer (Sysmex Medical Electronics, Kobe, Japan), including white blood cell count, erythrocyte count, HGB, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin concentration, and platelet count. The serum biochemical parameters included alanine aminotransferase (ALT), glutamic oxaloacetic transaminase (GOT), total protein (TP), albumin (ALB), globulin (GLB), blood urea nitrogen, creatinine, blood glucose, triglyceride and total cholesterol, which were determined by Hitachi 7150 analyzer (Tokyo, Japan).

Zhu Q., Qian Y., Yang Y., Wu W., Xie J, & Wei D. (2016). Effects of carbonyl iron powder on iron deficiency anemia and its subchronic toxicity. Journal of Food and Drug Analysis, 24(4), 746-753.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!